Latest Amyloid precursor protein Stories
“In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer’s disease,” said Stacy Pagos Haller, President and CEO of the American Health Assistance Foundation (AHAF), a nonprofit that identifies and funds exceptionally high-impact research worldwide through its Alzheimer’s Disease Research program.
Scientists, long searching for a cure for Alzheimer’s, a reporting a dramatic breakthrough: a drug that quickly reverses the pathological, cognitive and memory deficits in mice afflicted with the disease.
Memories in our brains are maintained by connections between neurons called "synapses".
A new study suggests that people who engage in mentally stimulating activities such as reading and playing games – particularly early in life -- may be lowering levels of a brain protein linked to Alzheimer's disease.
With a lack of effective treatments for Alzheimer's, most of us would think long and hard about whether we wanted to know years in advance if we were genetically predisposed to develop the disease.
A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published Dec. 14 in PLoS ONE.
One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell – can be restored by removing a plaque-forming protein in a mouse model of the disease.
Sluggish recycling of a protein-slicing enzyme could promote Alzheimer's disease.
In a development that sheds new light on the pathology of Alzheimer's disease (AD), a team of Whitehead Institute scientists has identified connections between genetic risk factors for the disease and the effects of a peptide toxic to nerve cells in the brains of AD patients.
- A volcanic mudflow.